Dramatic Improvement of MRI Abnormalities of HIV Encephalopathy after Suppressive Antiretroviral Therapy.
作者信息
Dietrich Devon K, Laidlaw Elizabeth, Hammoud Dima A, Pau Alice K, Smith Bryan R
机构信息
National Institute of Neurological Disorders and Stroke.
National Institute of Allergy and Infectious Diseases.
出版信息
AIDS. 2023 Jul;37(8):1339-1340. doi: 10.1097/QAD.0000000000003543.
Abstract
摘要
相似文献
1
Dramatic Improvement of MRI Abnormalities of HIV Encephalopathy after Suppressive Antiretroviral Therapy.
AIDS. 2023 Jul;37(8):1339-1340. doi: 10.1097/QAD.0000000000003543.
2
Therapy recommendations for HIV-associated neurocognitive disorders.
JAMA. 2008 Dec 3;300(21):2482; author reply 2482-3. doi: 10.1001/jama.2008.733.
3
Antiretroviral therapy intensification for HIV-associated neurocognitive disorder?
AIDS. 2023 Nov 1;37(13):2095-2096. doi: 10.1097/QAD.0000000000003694. Epub 2023 Sep 28.
4
Impact of antiretroviral therapy on HIV-related brain injury.
Clin Infect Dis. 2011 Jan 15;52(2):244-7. doi: 10.1093/cid/ciq052.
5
[HIV associated encephalopathy after highly active antiretroviral therapy (HAART)].
No To Shinkei. 2004 Apr;56(4):301-10.
6
HIV-associated neurocognitive disorders: perspective on management strategies.
Drugs. 2013 Jun;73(9):893-905. doi: 10.1007/s40265-013-0059-6.
7
Response to "Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment".
J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):656-7, author reply 657-8. doi: 10.1097/QAI.0b013e318157b0c8.
8
AIDS dementia complex: response to highly active antiretroviral therapy.
AIDS. 1999 Dec 3;13(17):2490-1. doi: 10.1097/00002030-199912030-00030.
9
Benefit or toxicity from neurologically targeted antiretroviral therapy?
Clin Infect Dis. 2010 Mar 15;50(6):930-2. doi: 10.1086/650744.
10
HIV-associated dementia in the era of highly active antiretroviral therapy (HAART).
Microbes Infect. 2011 May;13(5):419-25. doi: 10.1016/j.micinf.2011.01.004. Epub 2011 Jan 22.
引用本文的文献
1
Clinical and sociodemographic characteristics of Alzheimer's disease and related dementias among people with HIV.
AIDS. 2025 Jun 1;39(7):869-874. doi: 10.1097/QAD.0000000000004137. Epub 2025 Jan 30.
本文引用的文献
1
HIV, dementia and antiretroviral drugs: 30 years of an epidemic.
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1126-37. doi: 10.1136/jnnp-2012-304022. Epub 2013 Feb 1.
2
HIV-1 neuroimmunity in the era of antiretroviral therapy.
Neurobiol Dis. 2010 Mar;37(3):542-8. doi: 10.1016/j.nbd.2009.12.015. Epub 2010 Jan 4.
3
AIDS dementia complex.
Neurol Clin. 1999 Nov;17(4):861-81. doi: 10.1016/s0733-8619(05)70170-5.
4
Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group.
Ann Neurol. 1993 Apr;33(4):343-9. doi: 10.1002/ana.410330403.
5
Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.
AIDS. 1993 May;7(5):669-75.
6
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.
Neurology. 1993 Nov;43(11):2245-52. doi: 10.1212/wnl.43.11.2245.
7
AIDS dementia.
J Neurosci Nurs. 1989 Feb;21(1):24-9. doi: 10.1097/01376517-198902000-00005.
8
Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.
BMJ. 1989 Sep 30;299(6703):819-21. doi: 10.1136/bmj.299.6703.819.
Zotero 插件